Calcium elevation in nasal secretion has been linked with post-COVID-19 olfactory dysfunction. We conducted this systematic review and meta-analysis to test the efficacy of nasal secretion calcium-lowering drugs in post-COVID-19 persistent olfactory dysfunction.
(2024). Nasal Secretion Calcium Lowering Drugs in Post Covid-19 Olfactory Dysfunction. Egyptian Society of Diabetes and Lipidology Journal, 4(2), -. doi: 10.21608/esdlj.2024.456242
MLA
. "Nasal Secretion Calcium Lowering Drugs in Post Covid-19 Olfactory Dysfunction", Egyptian Society of Diabetes and Lipidology Journal, 4, 2, 2024, -. doi: 10.21608/esdlj.2024.456242
HARVARD
(2024). 'Nasal Secretion Calcium Lowering Drugs in Post Covid-19 Olfactory Dysfunction', Egyptian Society of Diabetes and Lipidology Journal, 4(2), pp. -. doi: 10.21608/esdlj.2024.456242
VANCOUVER
Nasal Secretion Calcium Lowering Drugs in Post Covid-19 Olfactory Dysfunction. Egyptian Society of Diabetes and Lipidology Journal, 2024; 4(2): -. doi: 10.21608/esdlj.2024.456242
)
